Holger Wesche - 28 Jan 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Scientific Officer
Signature
/s/ Holger Wesche by Laura Berezin, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Jan 2022
Net transactions value
$0
Form type
4
Filing time
01 Feb 2022, 15:09:09 UTC
Previous filing
15 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +135,000 $0.000000 135,000 28 Jan 2022 Common Stock 135,000 $5.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the total stock option will vest and become exercisable monthly on the same day of each month following the vesting commencement date of January 28, 2022, subject to the continuing employment of the Reporting Person on each vesting date.